Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics experienced significant selling activity over the past ninety days, with insiders offloading over ten million dollars in stock. These transactions, primarily planned sales, occurred amid a thirty-eight percent decline in share price. Despite a positive earnings report in August, leadership and directors have consistently reduced their holdings, reflecting a notable trend of divestment.
Ticker: MNPR Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Monopar Therapeutics Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
233.19
Quantity 4,710 -28.7%
Value US$1,416,383
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
260.81
Quantity 30,907 +22.9%
Value US$4,542,593
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
166.21
Quantity 17,467 -2.5%
Value US$1,387,475
3.3
Anderson Raymond Non-Executive Director
Transaction date
Sale
Price
70.04
Quantity 1,000 -21.8%
Value US$100,000
3.3
Anderson Raymond Non-Executive Director
Transaction date
Sale
Price
68.68
Quantity 1,000 -2.8%
Value US$100,000
3.3
Anderson Raymond Non-Executive Director
Transaction date
Sale
Price
67.06
Quantity 1,000 -7.8%
Value US$100,000
3.3
Anderson Raymond Non-Executive Director
Transaction date
Sale
Price
66.16
Quantity 1,000 -9.9%
Value US$100,000
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
70.10
Quantity 1,000 -100.0%
Value US$100,000
1.4
STARR CHRISTOPHER M Non-Executive Director
Transaction date
Planned sale
Price
79.67
Quantity 799 -13.4%
Value US$63,656
1.4
STARR CHRISTOPHER M Non-Executive Director
Transaction date
Planned sale
Price
78.82
Quantity 2,970 -33.2%
Value US$234,095
1.4
STARR CHRISTOPHER M Non-Executive Director
Transaction date
Planned sale
Price
78.09
Quantity 4,631 -34.1%
Value US$361,635
1.4
CHRISTOPHER STARR Director Non-Executive Director
Transaction date
Proposed sale
Price
79.67
Quantity 16,800
Value US$1,338,456
1.4
Robinson Chandler Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
89.79
Quantity 600 -0.6%
Value US$53,874
1.4
Robinson Chandler Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
88.97
Quantity 8,368 -7.7%
Value US$744,501
1.4
Robinson Chandler Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
87.96
Quantity 9,638 -8.2%
Value US$847,758
1.4
Robinson Chandler Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
87.15
Quantity 10,450 -8.1%
Value US$910,718
1.4
CHANDLER ROBINSON Director; Officer Executive Director
Transaction date
Proposed sale
Price
89.38
Quantity 29,056
Value US$2,597,025
RIOUX PATRICE Acting Chief Medical Officer
Transaction date
Planned sale
Price
111.26
Quantity 1 -0.0%
Value US$111
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
113.84
Quantity 590 -7.4%
Value US$67,166
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
112.93
Quantity 602 -7.0%
Value US$67,984
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
111.84
Quantity 1,098 -11.3%
Value US$122,800
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
110.65
Quantity 700 -6.7%
Value US$77,455
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
109.56
Quantity 615 -5.6%
Value US$67,379
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Planned sale
Price
108.83
Quantity 485 -4.2%
Value US$52,783
1.4
KIM TSUCHIMOTO Director Non-Executive Director
Transaction date
Proposed sale
Price
110.82
Quantity 8,180
Value US$906,508
PATRICE RIOUX Acting Chief Medical Officer Officer
Transaction date
Proposed sale
Price
110.82
Quantity 1
Value US$111
3.3
Anderson Raymond Non-Executive Director
Transaction date
Planned sale
Price
113.05
Quantity 1,802 -7.1%
Value US$203,716
3.3
Anderson Raymond Non-Executive Director
Transaction date
Planned sale
Price
110.07
Quantity 646 -2.5%
Value US$71,105
3.3
Anderson Raymond Non-Executive Director
Transaction date
Planned sale
Price
110.04
Quantity 694 -2.6%
Value US$76,368
3.3
RAYMOND WILLIAM ANDERSON Director Non-Executive Director
Transaction date
Proposed sale
Price
111.36
Quantity 6,284
Value US$699,786
2.3
Arthur Klausner Former Board Member
Transaction date
Proposed sale
Price
95.39
Quantity 5,000
Value US$476,967
2.3
Arthur Klausner Employer
Transaction date
Proposed sale
Price
97.05
Quantity 5,000
Value US$485,250
1.6
Vu Quan Anh Chief Financial Officer Officer
Transaction date
Purchase
Price
69.95
Quantity 1,500 New position
Value US$104,925
2.3
Arthur Klausner Board Member
Transaction date
Proposed sale
Price
67.16
Quantity 5,121
Value US$343,903
2.3
KLAUSNER ARTHUR J Non-Executive Director
Transaction date
Sale
Price
68.09
Quantity 461 -5.0%
Value US$31,389
2.3
KLAUSNER ARTHUR J Non-Executive Director
Transaction date
Sale
Price
67.06
Quantity 4,660 -33.6%
Value US$312,500
1.3
Tactic Pharma LLC Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
63.61
Quantity 550,229 -66.9%
Value US$34,999,957
1.4
STARR CHRISTOPHER M Non-Executive Director
Transaction date
Sale
Price
40.00
Quantity 16,800 -76.5%
Value US$672,020
1.4
Robinson Chandler Chief Executive Officer Executive Director
Transaction date
Sale
Price
40.00
Quantity 16,800 -18.6%
Value US$672,020
1.4
Tsuchimoto Kim R Non-Executive Director
Transaction date
Sale
Price
40.00
Quantity 8,904 -43.7%
Value US$356,171
1.4
STARR CHRISTOPHER M Director Non-Executive Director
Transaction date
Proposed sale
Price
40.00
Quantity 16,800
Value US$672,000
1.4
Tsuchimoto Kim R Director Non-Executive Director
Transaction date
Proposed sale
Price
40.00
Quantity 8,904
Value US$356,160
1.4
Robinson Chandler Officer; Director Executive Director
Transaction date
Proposed sale
Price
40.00
Quantity 16,800
Value US$672,000
1.3
Tactic Pharma LLC Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
35.00
Quantity 33,334 -3.9%
Value US$1,166,690
1.3
Tactic Pharma LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
35.00
Quantity 33,334
Value US$1,166,806
2.4
Radhakrishnan Karthik Chief Financial Officer Officer
Transaction date
Purchase
Price
16.25
Quantity 1,550 New position
Value US$25,188
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.74
Quantity 20,508 +12.4%
Value US$15,254
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.86
Quantity 12,000 +7.8%
Value US$10,320
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.90
Quantity 12,000 +8.5%
Value US$10,799
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.93
Quantity 12,000 +9.3%
Value US$11,176
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.91
Quantity 12,000 +10.2%
Value US$10,920
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.78
Quantity 12,000 +11.4%
Value US$9,360
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.76
Quantity 12,000 +12.8%
Value US$9,120
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.64
Quantity 12,000 +14.7%
Value US$7,732
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.64
Quantity 12,000 +17.2%
Value US$7,676
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
0.64
Quantity 12,000 +20.8%
Value US$7,643
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
3.15
Quantity 10,000 +70.2%
Value US$31,500
2.4
Cittadine Andrew Chief Operating Officer Officer
Transaction date
Purchase
Price
3.00
Quantity 6,053 +74.0%
Value US$18,159
1.3
Tactic Pharma LLC Chief Scientific Officer Large shareholder
Transaction date
Planned sale
Price
16.90
Quantity 11,929 -6.7%
Value US$201,600
1.3
Tactic Pharma LLC Chief Scientific Officer Large shareholder
Transaction date
Planned sale
Price
16.44
Quantity 16,384 -8.4%
Value US$269,353
1.3
Tactic Pharma LLC Chief Scientific Officer Large shareholder
Transaction date
Planned sale
Price
15.12
Quantity 29,996 -13.3%
Value US$453,540
1.3
Tactic Pharma LLC Chief Scientific Officer Large shareholder
Transaction date
Planned sale
Price
14.09
Quantity 24,224 -9.7%
Value US$341,316
1.3
Tactic Pharma LLC Chief Scientific Officer Large shareholder
Transaction date
Planned sale
Price
13.30
Quantity 42,467 -14.6%
Value US$564,811
Tsuchimoto Kim R Chief Financial Officer
Transaction date
Purchase
Price
8.00
Quantity 325 New position
Value US$2,600
Tactic Pharma LLC Chief Scientific Officer
Transaction date
Purchase
Price
8.00
Quantity 125,000 +75.0%
Value US$1,000,000
Hendricks Diane
Transaction date
Purchase
Price
8.00
Quantity 468,750 New position
Value US$3,750,000
Leo Karl
Transaction date
Purchase
Price
8.00
Quantity 314 New position
Value US$2,510
Leo Karl
Transaction date
Purchase
Price
8.00
Quantity 156,250 New position
Value US$1,250,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-04 2026-11-04 PlS Planned sale Non-Executive Director
4,710 -28.7%
233.19
US$1,416,383
4,710 -28.7% 233.19 US$1,416,383
2026-11-04 2026-11-04 PlS Planned sale Non-Executive Director
30,907 +22.9%
260.81
US$4,542,593
30,907 +22.9% 260.81 US$4,542,593
2026-11-04 2026-11-04 PlS Planned sale Non-Executive Director
17,467 -2.5%
166.21
US$1,387,475
17,467 -2.5% 166.21 US$1,387,475
2026-11-04 2026-11-02 S Sale Non-Executive Director
1,000 -21.8%
70.04
US$100,000
1,000 -21.8% 70.04 US$100,000
2026-11-04 2026-11-02 S Sale Non-Executive Director
1,000 -2.8%
68.68
US$100,000
1,000 -2.8% 68.68 US$100,000
2026-11-04 2026-11-02 S Sale Non-Executive Director
1,000 -7.8%
67.06
US$100,000
1,000 -7.8% 67.06 US$100,000
2026-11-04 2026-11-02 S Sale Non-Executive Director
1,000 -9.9%
66.16
US$100,000
1,000 -9.9% 66.16 US$100,000
2026-11-04 2026-11-02 PlS Planned sale Non-Executive Director
1,000 -100.0%
70.10
US$100,000
1,000 -100.0% 70.10 US$100,000
2026-10-05 2026-10-01 PlS Planned sale Non-Executive Director
799 -13.4%
79.67
US$63,656
799 -13.4% 79.67 US$63,656
2026-10-05 2026-10-01 PlS Planned sale Non-Executive Director
2,970 -33.2%
78.82
US$234,095
2,970 -33.2% 78.82 US$234,095
2026-10-05 2026-10-01 PlS Planned sale Non-Executive Director
4,631 -34.1%
78.09
US$361,635
4,631 -34.1% 78.09 US$361,635
2026-10-01 2026-10-01 PrS Proposed sale

Director

Non-Executive Director
16,800
79.67
US$1,338,456
16,800 79.67 US$1,338,456
2026-09-28 2026-09-24 PlS Planned sale

Chief Executive Officer

Executive Director
600 -0.6%
89.79
US$53,874
600 -0.6% 89.79 US$53,874
2026-09-28 2026-09-24 PlS Planned sale

Chief Executive Officer

Executive Director
8,368 -7.7%
88.97
US$744,501
8,368 -7.7% 88.97 US$744,501
2026-09-28 2026-09-24 PlS Planned sale

Chief Executive Officer

Executive Director
9,638 -8.2%
87.96
US$847,758
9,638 -8.2% 87.96 US$847,758
2026-09-28 2026-09-24 PlS Planned sale

Chief Executive Officer

Executive Director
10,450 -8.1%
87.15
US$910,718
10,450 -8.1% 87.15 US$910,718
2026-09-24 2026-09-24 PrS Proposed sale

Director; Officer

Executive Director
29,056
89.38
US$2,597,025
29,056 89.38 US$2,597,025
2026-08-27 2026-08-26 PlS Planned sale

Acting Chief Medical Officer

1 -0.0%
111.26
US$111
1 -0.0% 111.26 US$111
2026-08-27 2026-08-26 PlS Planned sale Non-Executive Director
590 -7.4%
113.84
US$67,166
590 -7.4% 113.84 US$67,166
2026-08-27 2026-08-26 PlS Planned sale Non-Executive Director
602 -7.0%
112.93
US$67,984
602 -7.0% 112.93 US$67,984
2026-08-27 2026-08-26 PlS Planned sale Non-Executive Director
1,098 -11.3%
111.84
US$122,800
1,098 -11.3% 111.84 US$122,800
2026-08-27 2026-08-26 PlS Planned sale Non-Executive Director
700 -6.7%
110.65
US$77,455
700 -6.7% 110.65 US$77,455
2026-08-27 2026-08-26 PlS Planned sale Non-Executive Director
615 -5.6%
109.56
US$67,379
615 -5.6% 109.56 US$67,379
2026-08-27 2026-08-26 PlS Planned sale Non-Executive Director
485 -4.2%
108.83
US$52,783
485 -4.2% 108.83 US$52,783
2026-08-26 2026-08-26 PrS Proposed sale

Director

Non-Executive Director
8,180
110.82
US$906,508
8,180 110.82 US$906,508
2026-08-26 2026-08-26 PrS Proposed sale

Acting Chief Medical Officer

Officer
1
110.82
US$111
1 110.82 US$111
2026-08-27 2026-08-25 PlS Planned sale Non-Executive Director
1,802 -7.1%
113.05
US$203,716
1,802 -7.1% 113.05 US$203,716
2026-08-27 2026-08-25 PlS Planned sale Non-Executive Director
646 -2.5%
110.07
US$71,105
646 -2.5% 110.07 US$71,105
2026-08-27 2026-08-25 PlS Planned sale Non-Executive Director
694 -2.6%
110.04
US$76,368
694 -2.6% 110.04 US$76,368
2026-08-25 2026-08-25 PrS Proposed sale

Director

Non-Executive Director
6,284
111.36
US$699,786
6,284 111.36 US$699,786
2026-07-10 2026-07-08 PrS Proposed sale

Former Board Member

5,000
95.39
US$476,967
5,000 95.39 US$476,967
2026-07-07 2026-07-07 PrS Proposed sale

Employer

5,000
97.05
US$485,250
5,000 97.05 US$485,250
2025-12-29 2025-12-26 B Purchase

Chief Financial Officer

Officer
1,500 New position
69.95
US$104,925
1,500 New position 69.95 US$104,925
2025-12-19 2025-12-18 PrS Proposed sale

Board Member

5,121
67.16
US$343,903
5,121 67.16 US$343,903
2025-12-19 2025-12-18 S Sale Non-Executive Director
461 -5.0%
68.09
US$31,389
461 -5.0% 68.09 US$31,389
2025-12-19 2025-12-18 S Sale Non-Executive Director
4,660 -33.6%
67.06
US$312,500
4,660 -33.6% 67.06 US$312,500
2025-09-26 2025-09-24 S Sale

Chief Executive Officer

Executive Director Large shareholder
550,229 -66.9%
63.61
US$34,999,957
550,229 -66.9% 63.61 US$34,999,957
2025-07-16 2025-07-14 S Sale Non-Executive Director
16,800 -76.5%
40.00
US$672,020
16,800 -76.5% 40.00 US$672,020
2025-07-16 2025-07-14 S Sale

Chief Executive Officer

Executive Director
16,800 -18.6%
40.00
US$672,020
16,800 -18.6% 40.00 US$672,020
2025-07-16 2025-07-14 S Sale Non-Executive Director
8,904 -43.7%
40.00
US$356,171
8,904 -43.7% 40.00 US$356,171
2025-07-14 2025-07-14 PrS Proposed sale

Director

Non-Executive Director
16,800
40.00
US$672,000
16,800 40.00 US$672,000
2025-07-14 2025-07-14 PrS Proposed sale

Director

Non-Executive Director
8,904
40.00
US$356,160
8,904 40.00 US$356,160
2025-07-14 2025-07-14 PrS Proposed sale

Officer; Director

Executive Director
16,800
40.00
US$672,000
16,800 40.00 US$672,000
2025-04-04 2025-04-02 S Sale

Chief Executive Officer

Executive Director Large shareholder
33,334 -3.9%
35.00
US$1,166,690
33,334 -3.9% 35.00 US$1,166,690
2025-04-02 2025-04-02 PrS Proposed sale

10% Stockholder

Large shareholder
33,334
35.00
US$1,166,806
33,334 35.00 US$1,166,806
2024-10-30 2024-10-28 B Purchase

Chief Financial Officer

Officer
1,550 New position
16.25
US$25,188
1,550 New position 16.25 US$25,188
2024-06-21 2024-06-20 B Purchase

Chief Operating Officer

Officer
20,508 +12.4%
0.74
US$15,254
20,508 +12.4% 0.74 US$15,254
2024-06-21 2024-06-18 B Purchase

Chief Operating Officer

Officer
12,000 +7.8%
0.86
US$10,320
12,000 +7.8% 0.86 US$10,320
2024-06-17 2024-06-17 B Purchase

Chief Operating Officer

Officer
12,000 +8.5%
0.90
US$10,799
12,000 +8.5% 0.90 US$10,799
2024-06-17 2024-06-14 B Purchase

Chief Operating Officer

Officer
12,000 +9.3%
0.93
US$11,176
12,000 +9.3% 0.93 US$11,176
2024-06-17 2024-06-13 B Purchase

Chief Operating Officer

Officer
12,000 +10.2%
0.91
US$10,920
12,000 +10.2% 0.91 US$10,920
2024-06-05 2024-06-04 B Purchase

Chief Operating Officer

Officer
12,000 +11.4%
0.78
US$9,360
12,000 +11.4% 0.78 US$9,360
2024-06-05 2024-06-03 B Purchase

Chief Operating Officer

Officer
12,000 +12.8%
0.76
US$9,120
12,000 +12.8% 0.76 US$9,120
2024-05-31 2024-05-31 B Purchase

Chief Operating Officer

Officer
12,000 +14.7%
0.64
US$7,732
12,000 +14.7% 0.64 US$7,732
2024-05-31 2024-05-30 B Purchase

Chief Operating Officer

Officer
12,000 +17.2%
0.64
US$7,676
12,000 +17.2% 0.64 US$7,676
2024-05-31 2024-05-29 B Purchase

Chief Operating Officer

Officer
12,000 +20.8%
0.64
US$7,643
12,000 +20.8% 0.64 US$7,643
2022-11-16 2022-11-15 B Purchase

Chief Operating Officer

Officer
10,000 +70.2%
3.15
US$31,500
10,000 +70.2% 3.15 US$31,500
2022-11-16 2022-11-14 B Purchase

Chief Operating Officer

Officer
6,053 +74.0%
3.00
US$18,159
6,053 +74.0% 3.00 US$18,159
2021-02-16 2021-02-11 PlS Planned sale

Chief Scientific Officer

Large shareholder
11,929 -6.7%
16.90
US$201,600
11,929 -6.7% 16.90 US$201,600
2021-02-16 2021-02-11 PlS Planned sale

Chief Scientific Officer

Large shareholder
16,384 -8.4%
16.44
US$269,353
16,384 -8.4% 16.44 US$269,353
2021-02-16 2021-02-11 PlS Planned sale

Chief Scientific Officer

Large shareholder
29,996 -13.3%
15.12
US$453,540
29,996 -13.3% 15.12 US$453,540
2021-02-16 2021-02-11 PlS Planned sale

Chief Scientific Officer

Large shareholder
24,224 -9.7%
14.09
US$341,316
24,224 -9.7% 14.09 US$341,316
2021-02-16 2021-02-11 PlS Planned sale

Chief Scientific Officer

Large shareholder
42,467 -14.6%
13.30
US$564,811
42,467 -14.6% 13.30 US$564,811
2019-12-20 2019-12-18 B Purchase Tsuchimoto Kim R

Chief Financial Officer

325 New position
8.00
US$2,600
325 New position 8.00 US$2,600
2019-12-20 2019-12-18 B Purchase Tactic Pharma LLC

Chief Scientific Officer

125,000 +75.0%
8.00
US$1,000,000
125,000 +75.0% 8.00 US$1,000,000
2019-12-20 2019-12-18 B Purchase Hendricks Diane
468,750 New position
8.00
US$3,750,000
468,750 New position 8.00 US$3,750,000
2019-12-20 2019-12-18 B Purchase Leo Karl
314 New position
8.00
US$2,510
314 New position 8.00 US$2,510
2019-12-20 2019-12-18 B Purchase Leo Karl
156,250 New position
8.00
US$1,250,000
156,250 New position 8.00 US$1,250,000